However, at 4 weeks a new “set point” was reached, with minimal subsequent change up to week 96 (−2.6 vs. −1.0 mL/min for Stribild and Atripla in the 0102 study, −1.8 vs. −4.4 mL/min for Stribild and TDF/FTC/ATV/RTV in the 0103 study) [18, 19]. In the 0114 study, patients in the COBI arm experienced greater

reductions in creatinine clearance (−13 vs. −9 mL/min) than in the RTV arm [33]. Five patients (1.4%) check details in the 0102 study, all in the Stribild arm, had renal events (reported as elevated serum creatinine in two, renal failure in two, Fanconi syndrome in one; a total of four patients had evidence of proximal tubulopathy that led to study drug discontinuation before week 48) [29]. Further two patients (0.6%) in the Stribild arm discontinued study drug between weeks 48 and 96, because of renal adverse events consisting of serum creatinine elevations not accompanied by proximal tubulopathy [31]. In the 0103 study, five patients (Stribild arm ABT-199 price 3, ATV/RTV arm 2) discontinued study drug due to renal events before week 96; none had evidence of proximal tubulopathy [32]. In the 0114 study, 1.7% and 1.4% of patients discontinued study medication for renal

events in the COBI and RTV arms, and 5 vs. 2 cases had proximal tubulopathy [33]. The low rate of renal discontinuations and renal tubular disease suggests an overall favourable renal safety profile of Stribild and COBI. Indeed, data from patients with creatinine clearance 50–89 mL/min who initiated Stribild Oxymatrine or substituted RTV with COBI observed no increased rate of renal toxicity or renal discontinuations [36]. The increases in serum creatinine concentration and the reductions in estimates of creatinine clearance and glomerular filtration rate are unlikely to be of clinical importance. Some of the renal discontinuations were likely to be due to patients meeting pre-specified criteria for discontinuation

rather than secondary to overt renal toxicity. Nonetheless, the population included in the clinical trials was at low risk of kidney injury and despite this a small number developed significant renal tubular disease requiring drug discontinuation. The risk factors for TDF-induced Fanconi syndrome and renal tubular disease remain poorly defined but may point to an interaction between COBI and tenofovir at renal tubular level, as previously suggested for RTV [37]. Although such an interaction is not predicted by in vitro studies (Fig. 1), clinicians will need to remain alert to the nephrotoxic potential of Stribild in clinical practice. Fig. 1 Effect of various drugs on tubular creatinine secretion [17]. Tubular secretion of creatinine and tenofovir is mediated through distinct membrane transporter molecules. Based on in vitro experiments, no interaction between cobicistat and tenofovir is predicted.

However, the burdens observed in the galU mutant-infected mice were significantly lower (p < 0.01) in the spleens and livers (p < 0.001) of infected mice at the 96 h time point. Collectively, these results reveal that despite its normal replication/dissemination phenotypes, the galU mutant is more readily cleared than WT FT. Figure 3 Mutation of the galU gene does click here not attenuate infectivity of FT in vivo. C57BL/6 mice (4/group) were infected intranasally with 5 × 104 CFU (50 × LD50 for FT LVS) of either the WT or galU mutant strain of FT LVS. Organs were harvested at 24, 48, 72 and 96 hours p.i.

and CFU/g of organ was determined for lungs, liver, and spleen. The lower limit of detection was 20 CFU/g. Statistical analyses were performed via two-way ANOVA with a Bonferroni

multiple comparisons post test and all significant differences are indicated as follows: ** P < 0.01 Angiogenesis inhibitor and *** P < 0.0001. The data shown is representative of two independent experiments of similar design. Mutation of galU alters the kinetics of innate immune responses To determine whether differences in innate immune recognition of infection might be responsible for the dramatic difference in the outcome of disease with the galU mutant vs. WT FT, we analyzed the kinetics of immune cell infiltration into the lungs following infection. BALF were collected from each mouse at the time of sacrifice and a series of flow cytometric analyses was performed. The numbers of macrophages, dendritic cells, and NK cells recruited into the lungs of mice infected with the galU mutant and WT FT were similar at each time point (data not shown). However, higher numbers of neutrophils were observed in the lungs of mice infected with the galU mutant at the 24- and 48-hour time points, with peak numbers of neutrophils measured at 48 hours post-infection (Figure 4A). In contrast, SPTBN5 the kinetics of recruitment of neutrophils into the lungs of mice infected with WT FT was much slower (Figure 4A), peaking five days post-infection (data not shown). Figure 4 Neutrophil recruitment

and chemokine expression in the lungs following infection with the galU mutant. C57Bl/6J mice (4/group) were infected intranasally with 5 × 104 CFU (or 50 × LD50) of either the WT or galU mutant strain of FT and BALF was collected from individual mice at 24, 48, 72 and 96 hours post-infection. Flow cytometric analyses were performed on the cells recovered from BALF to determine the numbers of neutrophils at each timepoint. Statistical analyses were performed via two-way ANOVA with a Bonferroni multiple comparisons post-test and statistically significant differences (P < 0.05) are indicated (*) (Panel A). The concentrations of KC, G-CSF, MIG, and IL-10 (Panel A) and TNF-α, MIP-1α, MIP-1β, MIP-2, and MCP-1 (Panel B) in BALF at the 24 and 48 hour time points, respectively, were determined using a Luminex multiplex kit. Statistical analyses were performed using unpaired t tests.

Scand J Work Environ Health 33:233–239PubMed Cox DR, Snell EJ (1968) A general definition of residuals. J R Stat Soc Ser B Methodol 30:248–275 Crook J, Moldofsky H (1994) The probability of recovery and return to work

from work disability as a function of time. Qual Life Res 3(suppl 1):97–109. doi:10.​1007/​BF00433383 CrossRef Gjesdal S, Bratberg E (2002) The role of gender in long-term sickness absence and transition to permanent disability benefits. Eur J Public Health 12:180–186. doi:10.​1093/​eurpub/​12.​3.​180 PubMedCrossRef BVD-523 Henderson M, Glozier N, Elliot KH (2005) Long term sickness absence. BMJ 330:802–803. doi:10.​1136/​bmj.​330.​7495.​802 PubMedCrossRef Hensing G (2004) Chapter

4. Methodological aspects in sickness-absence research. Scand J Public Health 32:44–48. doi:10.​1080/​1403495041002184​4 CrossRef Hesselius P (2007) Does sickness absence increase the risk of unemployment? J Socio-Econ 36:288–310. doi:10.​1016/​j.​socec.​2005.​11.​037 CrossRef Joling C, Groot W, Janssen PPM (2006) Duration dependence in sickness absence: how can we optimize disability management intervention strategies? J Occup Environ Med 48:803–814. doi:10.​1097/​01.​jom.​0000222583.​70927.​3e PubMedCrossRef Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481. doi:10.​2307/​2281868 CrossRef Kivimäki M, Head J, Ferrie JE, Shipley MJ, Vahtera J, Marmot MG (2003) Sickness absence as a global measure of health: evidence from mortality in the Whitehall II prospective cohort study. BMJ 327:364–368. doi:10.​1136/​bmj.​327.​7411.​364 ABT-888 supplier PubMedCrossRef Koopmans PC, Roelen CAM, Groothoff

JW (2008) Frequent and long-term absence as a risk factor for work disability and job termination among employees in the private sector. Occup Environ Med 65:494–499PubMedCrossRef Krause N, Frank JW, Dasinger LK, Sullivan TJ, Sinclair SJ (2001) Determinants of duration of disability and return-to-work after work-related injury and illness: challenges for future research. Am J Ind Med 40:464–484. doi:10.​1002/​ajim.​1116 PubMedCrossRef Lie SA, Eriksen HR, Ursin H, Hagen EM (2008) A multi-state model for sick-leave PFKL data applied to a randomized control trial study of low back pain. Scand J Public Health 36:279–283. doi:10.​1177/​1403494807086979​ PubMedCrossRef Lund T, Labriola M, Christensen KB, Bültmann U, Villadsen E (2006) Return to work among sickness-absent Danish employees: prospective results from the Danish Work Environment Cohort Study/National Register on Social Transfer Payments. Int J Rehabil Res 29:229–235. doi:10.​1097/​01.​mrr.​0000210056.​24915.​c2 PubMedCrossRef Meira-Machado LF, Una-Alvarez JD, Cadarso-Suarez C, Andersen P (2008) Multi-state models for the analysis of time-to-event data. Stat Methods Med Res. doi:10.

As shown previously [27], western blot analysis of eIF4E correlated with TLK1B protein expression. At the same time, eIF4E expression (determined by both western blot and TMA-IHC) did not correlate with ER, PR or HER-2/neu. Consistent with these results, the lack of correlation of eIF4E (detected by western blot) with ER, PR, and HER-2/neu was previously reported [18, 19].

Our results confirm and extend the results previously described by Yang and colleagues [20]. In their study, which utilized a multi-tumor TMA from TARP http://​www.​cancer.​gov/​tarp/​, they found eIF4E, VEGF, and cyclin D1 were elevated in breast tumors compared to combined normal tissues [20]. The authors also found that eIF4E levels

were moderately correlated Opaganib mw with VEGF and cyclin D1 expression in breast (Spearman’s rank correlation) [20]. Among the major differences between the two studies: this study focused solely on breast cancer, and included validation of western blot and IHC analysis of the same samples. We also verified coefficients of variance to demonstrate plug-to-plug reproducibility. Furthermore, we examined a broader range of downstream proteins, and included more negative controls. Also, we used the ARIOL imaging system whereas they used ACIS. The strength of these two studies supports the idea that IHC can be used in a TMA format for evaluating critical oncogenic proteins. In comparing western blot to IHC, there are advantages and disadvantages to both procedures. One advantage to western blot, traditionally, is that it has provided a greater CH5424802 molecular weight dynamic range for quantitation than IHC. This is especially true, historically, as IHC has

been semi-quantitative and subject to scoring methods. However, with the wider availability of IHC quantitation systems such as ARIOL, IHC has become more quantitative. This also provides potential standardization between different research institutions. The use of TMAs rather than individual IHCs for each specimen also provides institutions the PJ34 HCl ability to analyze a larger set of specimens at a time using similar staining and quantitation procedures. Another advantage to western blot, however, is that the molecular weights of the proteins can be estimated based on the molecular weight standards that are also resolved on the gel. This is particularly important if the antibodies exhibit non-specific staining. The protein of interest can be isolated from the non-specific staining and quantitated. The best way to overcome the problem of non-specific staining in IHC is to use the most specific antibodies available and to optimize the dilutions of antibodies and other staining conditions. Comparisons of positive and negative controls also help confirm specificity.

Interestingly, one polymorphism (position 939) was found to be present in all the strains. One genotype was represented by 93%

(65+/70) of the strains, and the other three genotypes were represented by only one or two strains. Two polymorphisms were found to be non-synonymous and gave three FK228 in vivo different genotypes in the AA sequences: for the first polymorphism, serine was coded in place of alanine in AA position 45; for the second polymorphism, three AA (TKE) were inserted into AA position 191. These two polymorphisms were situated in the N-terminal part of the gene. Nevertheless, when we compared polymorphisms regarding the host and the pathotype (EPEC or EHEC), none was found to be specific to the bovine or the human isolates (p < 0.05) or to EPEC or EHEC pathotype. Table 2 tir β gene polymorphism (aa: amino acid, A: alanine, S: serine, T: threonine, K: lysine, E: glutamic acid)   Number of strains Polymorphism

1 Polymorphism 2 Polymorphism 3 Polymorphism 4 Polymorphism 5         (S) 1080 G => T (S) 1302 C => T (NS) 133 T => G (NS) insertion1 571 GATACAAAG (S) 939 G => A   Human Bovine       45 aa: S => A 191 aa: TKE     0 2 Genotype 1 + – - – +   2 0 Genotype 2 – + – + +   1 0 Genotype 3 selleck products – - + – +   25 40 Genotype Amylase 4 – - – - + Total 28 42             Polymorphisms in the tccP2 gene For the tccP2 gene, seven genotypes (Table 3) were detected in the collection. All had been previously described

[23, 24]. The tccP2 variant described in reference strain 11368 (accession number AB253564) was found to be present in 34% (24+/70) of the strains. The tccP2 variant described in reference strain EC38/99 (accession number AB275131) was present in 17% (12+/70) of the strains. tccP2 variants described in reference strains 12009 and CB00225 (accession number AB253581 and AB275122 respectively) were both present in 6% (4+/70) of the strains. Three tccP2 variants described in reference strains ED411, ED71 and 5905 (accession number AB253567, AB253576 and AB356001 respectively) were represented by only one strain each. None of the variants was found to be specific to the bovine or the human isolates (p < 0.05). Nevertheless, the two major variants were statistically associated with the pathotype (p < 0.01): the tccP2 gene AB275131 was statistically associated with the EPEC strains in comparison with the EHEC strains and the tccP2 gene AB253564 was statistically associated with the EHEC strains in comparison with the EPEC strains.

2006, 2009, 2010; Schopf 2006), is particularly noteworthy since such distinctive structures evidently require for their formation “highly motile mat builders” such as oscillatoriacean cyanobacteria (Grotzinger and Knoll 1999, pp. 342–343). Fig. 2 Forty-eight Archean geological units reported to contain stromatolites. Data from Hofmann (2000) and Schopf (2006) hypoxia-inducible factor pathway Fig. 3 Archean-age microbially laminated stromatolites. a Domical, pseudocolumnar and branching stromatolites, overlain by rippled sediments,

and b a domical stromatolite from the ~2,723-Ma-old Tumbiana Formation (Fortescue Group) of Western Australia. c Conical stromatolite and d stratiform and conical stromatolites, from the ~2,985-Ma-old Insuzi Group, South Africa. e–g Laterally linked conical stromatolites from the ~3,388-Ma-old Strelley Pool Chert of Western Australia Cellular fossils Two principal processes preserve cellular microbial fossils: compression and permineralization. Compression-preserved microorganisms occur in fine-grained detrital sediments such as shales and siltstones, pressed and flattened along bedding planes as the sediment lithified.

Such compression-preserved microbes are poorly known from the Phanerozoic, largely neglected by Phanerozoic paleontologists who focus chiefly on megascopic remains, but they are appreciably better LY2606368 documented in the Precambrian (e.g., Butterfield 2009). The microbial fossil record is best known from microorganisms preserved by permineralization. Of all modes of fossil preservation, this process (known also as petrification) provides the most faithful representation of life-like morphology. Cyclin-dependent kinase 3 Such preservation, common for plants and fungi as well as fossilized prokaryotes, results from the pervasion of mineral-charged solutions into cells during

the early stages of diagenesis, prior to their decay and disintegration. The permeating fluids infill microscopic voids—replacing the watery milieu of the cellular components—to produce a mineral-infused inorganic–organic mix that preserves physically robust structures such as organic-rich cell walls. As a result, both the organismal morphology and cellular anatomy of such fossils can be preserved in microscopic detail. The most common such permineralizing matrix is silica, fine-grained (cryptocrystalline) quartz, the mineral that comprises the rock-type known as chert. Hundreds of microbe-preserving cherts are now known from the Precambrian when silica was abundant in the world’s oceans, well before the Phanerozoic appearance of silica-biomineralized sponges, diatoms and radiolarians that today regulate the oceanic silica budget. As shown here, such cherts can contain exquisitely preserved fossil microbes. Filamentous cyanobacteria Among the several taxonomic families of filamentous cyanobacteria, stromatolite-building members of the Oscillatoriaceae have the most extensive fossil record, represented by diverse fossils in hundreds of ancient microbial communities (e.g., Fig.

Factors influencing the prevalence of vertebral fractures are reported in Table 2. Regarding

sex distribution, the prevalence of vertebral fractures was higher in men than in women, and also the percentage in which such fractures were unknown was higher in men (75% in men and 65% in women). Limiting these data to moderate and severe fractures only, the prevalence in men was 15% (131/851) and 12% in women (191/1,573). Table 2 Univariate analysis of variables influencing vertebral fracture status Factor Number % of selleck compound total Number with VF Percent p (t test) Sex         <0.0001   Male 851 35.1% 232 27%     Female 1573 64.9% 309 20%   Female menopausal status         <0.0001   Pre 332 21.2% 22 7%     Post 1241 78.8% 287 23%   Visit status         0.31   First 1641 67.7% 376 23%     Follow-up 783 32.3% 165 21%   Osteoporosis suspicion         <0.0001   Primary 662 27.3% 221 33%     Secondary 1762 72.7% 320 18%   Recent low-energy fracture         <0.0001   Yes 570 23.5% 190 33%     No 1854 76.5% 351 19%   Steroid use (ever)         0.006   Yes 960 39.6% 187 20%     No 1464 60.1% Selleck Navitoclax 354 25%   Smoker         0.76

  Yes 593 24.5% 135 23%     No 1831 75.5% 406 22%   Ever previous fracture         <0.0001   Yes 1251 52% 346 28%     No 1173 48% 195 17%   X-spine in last 2 years         <0.0001   Yes 838 35% 276 33%     No 1586 65% 265 17%   Self-reported posture change         <0.0001   Yes 400 17% 174 44%     No 2024 83% 367 18%   X-spine requested with BMD request         <0.0001   Yes 190 41% 66 35%     No 276 59% 54 20%   The age distribution of vertebral PR-171 manufacturer fractures is presented in Table 3. As expected the prevalence of vertebral fractures increases with age and reached approximately 50% in patients older than 70 years. Of interest, the proportion of moderate and severe fractures also increased with age. Further stratifying this for sex the rate of vertebral fractures in men was 10%, 19%, 21%, 28%, 36%, 49%, 50% in the age groups of Table 3, versus 5%,

7%, 11%, 18%, 22%, 47%, 49% in women. Table 3 Age distribution and prevalence of vertebral fractures (VF) Age group N in age group N with VF % with VF % with mild VF only % with moderate or severe VF 11–20 38 2 5.3 5.3 0 21–30 191 14 7.3 5.2 2.1 31–40 275 31 11.2 5.8 5.4 41–50 386 58 15.0 8.5 6.5 51–60 728 155 21.3 9.5 11.8 61–70 508 139 27.4 10.4 17.0 71–80 216 103 47.7 13.0 34.7 81–90 81 39 48.1 11.1 37.0 >90 1 0 – – – Total 2424 541 22.1 8.9 13.3 Other factors that were associated with higher prevalence of vertebral fractures were postmenopausal status of women as compared to premenopausal status, primary osteoporosis vs. secondary osteoporosis, recent low-energy fracture, use of steroids, history of any fracture, patients who underwent spinal radiograph in the last 2 years and self-reported posture change. No difference was found in vertebral fracture prevalence in those who came for a first vs. follow-up visit and in smokers vs. non-smokers.

PubMedCentralPubMed 51. Bonifait L, Grignon L, Grenier D: Fibrinogen induces biofilm formation by Streptococcus suis and enhances its antibiotic resistance. Appl Environ Microbiol 2008, 74:4969–4972.PubMedCentralPubMedCrossRef 52. Olson ME, Ceri H, Morck DW, Buret AG, Read RR: Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res 2002, 66:86–92.PubMedCentralPubMed 53. Brisebois LM, Charlebois R, Higgins R, Nadeau M:

Prevalence of Streptococcus suis in four to eight week old clinically healthy piglets. Can J Vet Res 1990, APO866 chemical structure 54:174–177.PubMedCentralPubMed 54. MacInnes JI, Gottschalk M, Lone AG, Metcalf DS, Ojha S, Rosendal T, Watson SB, Friendship RM: Prevalence of Actinobacillus pleuropneumoniae , Actinobacillus suis , Haemophilus parasuis , Pasteurella multocida , and Streptococcus suis in representative Ontario swine herds. Can J Vet Res 2008, 72:242–248.PubMedCentralPubMed 55. Amass SF, Wu CC, Clark LK: Evaluation of antibiotics for the elimination of the tonsillar carrier state of Streptococcus suis in pigs. J Vet Diagn Invest 1996, 8:64–67.PubMedCrossRef 56. Smith HE, Veenbergen V, Van der Velde J, Damman M, Wisselink HJ, Smits MA: The cps

genes of Streptococcus suis serotypes 1, 2, and 9: development of rapid serotype-specific PCR assays. J Clin Microbiol 1999, 37:3146–3152.PubMedCentralPubMed Veliparib 57. Schubert A, Zakikhany K, Schreiner M, Frank R, Spellerberg B, Eikmanns BJ, Reinscheid DJ: A fibrinogen receptor from group B Streptococcus interacts with fibrinogen by repetitive units with novel ligand binding sites. Mol Microbiol 2002, 46:557–569.PubMedCrossRef 58. Rohde M, Muller E, Chhatwal GS, Talay SR: Host cell caveolae act as an entry-port for group A streptococci. Cell Microbiol 2003, 5:323–342.PubMedCrossRef

59. Molinari G, Talay SR, Valentin-Weigand P, Rohde M, Chhatwal GS: The fibronectin-binding protein of Streptococcus pyogenes , SfbI, is involved in the internalization of group A streptococci by epithelial cells. Infect Immun 1997, 65:1357–1363.PubMedCentralPubMed Orotic acid Competing interests The authors declare that they have no competing interests. Authors’ contributions JW and DW carried out the experiments and analyzed the data. RB helped with the design of the study and draft of the manuscript. JW, RG and PVW conceived the study, participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.”
“Background Acinetobacter baumannii has emerged as a major cause of nosocomial infections, especially in intensive care units [1]. Both its ability to acquire resistant determinants and to adapt to harsh environments has made A. baumannii a successful pathogen [2]. A. baumannii has high rates of resistance to many available antibiotics in clinical practice. For example, imipenem-resistant A. baumannii constituted > 50% of a worldwide collection of clinical samples between 2005 and 2009 [3].

This protein set included 19 predicted proteins with the peptidoglycan anchor LPXTG-like motif, 15 predicted Cbps, 36 proteins with putative lipid-attachment motifs (predicted lipoproteins) [28]. In the R6 strain, a comparable set of proteins display bacterial surface motifs even though not in the same number: 13 LPXTG proteins linked to the peptidoglycan, 10 Cbps and 109 lipoproteins (this number is different than in the

TIGR4 strain probably because the authors used different algorithms to predict the lipoproteins). The authors mentioned that overall 471 proteins contain a predicted signal peptide sequence, an indication of their bacterial surface location, either through membrane anchoring or by secretion

in the extracellular space and bound somehow to the cell wall [29]. To date, pneumococcal surface EMD 1214063 mw proteins acting as virulence factors and IDO inhibitor playing a role in colonization and disease are overall about 15 (mainly the ones described previously in this text). Taking into account the large number of predicted surface-exposed, and the lack of knowledge on key aspects of the physiopathology of the pneumococcus, we assume that understanding of pneumococcal disease might greatly profit from the study of yet unstudied surface-exposed proteins. In order to identify new host-pneumococcal interactions that may play roles in colonization and disease progress, we have designed a global screening strategy. We first evaluated the ability of the pneumococcus to adhere to host components. Then we cloned and expressed pneumococcal proteins from the Cbps and the LPXTG protein families to systematically test the interactions of these proteins against host proteins. We thus obtained a map of pneumococcal surface proteins interactions with twelve mammalian C-X-C chemokine receptor type 7 (CXCR-7) proteins putatively encountered during the colonization and/or invasion stages. This work allowed the identification of new protein-protein interactions between Cbp, LPXTG proteins and host proteins, and gives renewed view of the respective roles of Cbp and LPXTG proteins, opening the route

for in depth study of the interactions uncovered. Results Binding of pneumococcal strains R6 and TIGR4 to host proteins We first investigated the ability of pneumococcal strains to interact with a wide range of host proteins likely encountered by bacterial pathogens [30]: extracellular matrix proteins (collagens, elastin, fibronectin, laminin, mucin), circulating plasma proteins acting in the coagulation cascade (fibrinogen, plasminogen) and proteins involved in the innate immune defense (lactoferrin, CRP, SAP, factor H). Binding of the R6 strain to these host proteins was tested in a solid-phase assay. Host proteins or Bovine Serum Albumine (BSA) as a negative control were coated on a multi-well plate.

Acta Crystallogr Sect D 63:951–960CrossRef Dau H, Andrews JC, Roelofs TA, Latimer MJ, Liang W, Yachandra VK, Sauer K, Klein MP (1995) Structural consequences of ammonia

binding to the manganese cluster of the photosynthetic oxygen-evolving complex: an X-ray absorption study of isotropic and oriented photosystem II particles. Biochemistry 34:5274–5287CrossRefPubMed Eisenberger P, Brown GS (1979) Study MK1775 of disordered systems by EXAFS: limitations. Solid State Commun 29:481–484CrossRef Eisenberger P, Kincaid BM (1978) EXAFS: new horizons in structure determinations. Science 200:1441–1447CrossRefPubMed Flank AM, Weininger M, Mortenson LE, Cramer SP (1986) Single-crystal EXAFS of nitrogenase. J Am Chem Soc 108:1049CrossRef George GN, Prince RC, Cramer SP (1989) The manganese site of the photosynthetic water-splitting enzyme. Science 243:789–791CrossRefPubMed George GN, Cramer SP, Frey TG, Prince RC (1993) X-ray absorption spectroscopy of oriented cytochrome oxidase. Biochim Biophys Acta 1142:240–252CrossRefPubMed

George GN, Pickering IJ, Kisker C (1999) X-ray absorption spectroscopy of chicken sulfite oxidase crystals. Inorg Chem 38:2539CrossRef Haumann M, Liebisch P, Muller C, Barra M, Grabolle M, Dau H (2005) Photosynthetic O2 formation tracked by time-resolved X-ray experiments. Science 310:1019–1021CrossRefPubMed Haumann M, Barra M, Loja P, Loscher S, Krivanek R, Grundmeier A, Andreasson LE, Dau H (2006) Bromide does selleck chemicals not bind to the Mn4Ca complex in its S1 state in Cl−-depleted and Br−-reconstituted oxygen-evolving photosystem II: evidence from X-ray absorption spectroscopy at the Br K-edge. Biochemistry 45:13101–13107CrossRefPubMed Koningsberger DC,

Prins R (eds) (1988) X-ray absorption: principles, applications, techniques of EXAFS, SEXAFS and XANES. Wiley, New York Latimer MJ, DeRose VJ, Mukerji I, Yachandra VK, Sauer K, Klein MP (1995) DOK2 Evidence for the proximity of calcium to the manganese cluster of photosystem II: determination by X-ray absorption spectroscopy. Biochemistry 34:10898–10909CrossRefPubMed Lytle FW, Sayers DE, Stern EA (1989) Report of the international workshop on standards and criteria in X-ray absorption-spectroscopy (1988), Brookhaven National Laboratory. Physica B 158:701–722CrossRef Messinger J, Robblee JH, Bergmann U, Fernandez C, Glatzel P, Visser H, Cinco RM, McFarlane KL, Bellacchio E, Pizarro SA, Cramer SP, Sauer K, Klein MP, Yachandra VK (2001) Absence of Mn-centered oxidation in the S2 → S3 transition: implications for the mechanism of photosynthetic water oxidation. J Am Chem Soc 123:7804–7820CrossRefPubMed Mukerji I, Andrews JC, Derose VJ, Latimer MJ, Yachandra VK, Sauer K, Klein MP (1994) Orientation of the oxygen-evolving manganese complex in a photosystem-II membrane preparation: an X-ray-absorption spectroscopy study.